PD1+ and PD-L1+ cancer cells were detected in 100% of FMCs, irrespective of the tumor molecular subtype [158], whereas in rare FMT histotypes, results differed, with PD-L1+ cancer cells identified in 46% of cases [162]. This evidence concerns the gene CD274 and neoplasm.